Literature DB >> 35220591

The Central Role of pH in the Clinical Pharmacology of Nicotine: Implications for Abuse Liability, Cigarette Harm Reduction and FDA Regulation.

Neal L Benowitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35220591      PMCID： PMC9035094          DOI： 10.1002/cpt.2555

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.903


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and pharmacodynamics of moist snuff in humans.

Authors:  R V Fant; J E Henningfield; R A Nelson; W B Pickworth
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Compensatory Puffing With Lower Nicotine Concentration E-liquids Increases Carbonyl Exposure in E-cigarette Aerosols.

Authors:  Leon Kosmider; Catherine F Kimber; Jolanta Kurek; Olivia Corcoran; Lynne E Dawkins
Journal:  Nicotine Tob Res       Date:  2018-07-09       Impact factor: 4.244

Review 3.  Nicotine addiction.

Authors:  Neal L Benowitz
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

4.  Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users.

Authors:  Neal L Benowitz; Caroline C Renner; Anne P Lanier; Rachel F Tyndale; Dorothy K Hatsukami; Bruce Lindgren; Irina Stepanov; Clifford H Watson; Connie S Sosnoff; Peyton Jacob
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-04-06       Impact factor: 4.254

5.  The pH of Smokeless Tobacco Determines Nicotine Buccal Absorption: Results of a Randomized Crossover Trial.

Authors:  Jess Wilhelm; Elena Mishina; Lauren Viray; Antonio Paredes; Wallace B Pickworth
Journal:  Clin Pharmacol Ther       Date:  2021-12-17       Impact factor: 6.875

6.  Balancing Consideration of the Risks and Benefits of E-Cigarettes.

Authors:  David J K Balfour; Neal L Benowitz; Suzanne M Colby; Dorothy K Hatsukami; Harry A Lando; Scott J Leischow; Caryn Lerman; Robin J Mermelstein; Raymond Niaura; Kenneth A Perkins; Ovide F Pomerleau; Nancy A Rigotti; Gary E Swan; Kenneth E Warner; Robert West
Journal:  Am J Public Health       Date:  2021-08-19       Impact factor: 9.308

7.  Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame.

Authors:  Neal L Benowitz; Gideon St Helen; Evangelia Liakoni
Journal:  J Clin Pharmacol       Date:  2021-08       Impact factor: 2.860

8.  Characterization of Total and Unprotonated (Free) Nicotine Content of Nicotine Pouch Products.

Authors:  Stephen Stanfill; Hang Tran; Robert Tyx; Carolina Fernandez; Wanzhe Zhu; Kristy Marynak; Brian King; Liza Valentín-Blasini; Benjamin C Blount; Clifford Watson
Journal:  Nicotine Tob Res       Date:  2021-05-26       Impact factor: 4.244

9.  Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids.

Authors:  Arit M Harvanko; Christopher M Havel; Peyton Jacob; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244
  9 in total
  1 in total

1.  E-cigarettes to Augment Stop Smoking In-person Support and Treatment with varenicline (E-ASSIST): a pragmatic randomised controlled trial.

Authors:  Harry Tattan-Birch; Loren Kock; Jamie Brown; Emma Beard; Linda Bauld; Robert West; Lion Shahab
Journal:  Nicotine Tob Res       Date:  2022-06-23       Impact factor: 5.825
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.